Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4649794011 | Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4649795012 | Viloxazine (as viloxazine hydrochloride) 150 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5301691000052110 | viloxazin (som viloxazinhydroklorid) 150 mg, depåkapsel | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Viloxazine only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Prolonged-release oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Plays role | Antidepressant therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Viloxazine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Viloxazine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR